 NGM936, a ILT3 x CD3 bispecific T cell engager product candidate, potently induced T cell dependent cytotoxicity TDCC against ILT3 AML cells while inducing minimal cytokine release in preclinical in vivo and in vitro studies Immunoglobulin-like transcript 3 ILT3 is a highly specific marker of acute myeloid leukemia AML with monocytic differentiation and is not ... The post NGM Bio Gives Presentation Featuring Preclinical Characterization of NGM936 at 2022 ASH Annual Meeting appeared fi... 